Why Is Invo Bioscience (INVO) Stock Up 85% Today?

Invo Bioscience (NASDAQ:INVO) stock is rocketing higher on Wednesday alongside its earnings report for the fourth quarter of 2023.The healthcare services fertility company reported a net loss of $2 million during the quarter. That’s an improvement over its net loss of $2.8 million from the same period of the year prior.Revenue reported by Invo Bioscience comes in at $1.38 million for Q4 2023. That’s a massive 397% increase over its Q4 2022 revenue of $278,142.Invo Bioscience CEO Steve Shum said the followin ...